EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Comparison of Short‐Term Outcomes Between Robotic‐Assisted and Open Pancreatoduodenectomy: A Retrospective Cohort Study With Inverse Probability of Treatment Weighting (IPTW) Analysis

Xi‐Tai Huang, Jin‐Zhao Xie, Jian‐Peng Cai, Qiong‐Cong Xu, Wei Chen, Chen‐Song Huang, Bin Li, Jia‐Ming Lai, Li‐Jian Liang, Xiao‐Yu Yin

The International Journal of Medical Robotics and Computer Assisted Surgery · 2025-04 · 21 (2)

DOI: 10.1002/rcs.70057 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background The advantages of robotic‐assisted pancreatoduodenectomy (RPD) in comparison with open pancreatoduodenectomy (OPD) have not been well‐established. We aimed to compare their short‐term outcomes by inverse probability of treatment weighting (IPTW) analysis. Methods Patients who underwent RPD/OPD at our hospital were recruited. Stabilised IPTW were performed to adjust observed covariates. Short‐term outcomes were compared. Results After IPTW, the effective sample comprised 807 patients (199 RPD, 608 OPD) with balanced clinicopathological characteristics. RPD had a longer operation time, fewer intraoperative blood loss (IBL), and lower blood transfusion rate than OPD. RPD was associated with a lower incidence of clinically relevant postoperative pancreatic fistula and reoperation but did not reach statistical significance. In pancreatic adenocarcinoma, RPD had a significantly higher number of lymph nodes examined. There were no significant differences in postoperative morbidities and length‐of‐stay. Conclusions RPD was associated with fewer IBL and transfusion rates than OPD. RPD can be considered feasible and safe.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →